Mon, Jul 28, 2014, 3:20 PM EDT - U.S. Markets close in 40 mins.

Recent

% | $
Click the to save as a favorite.

Celgene Corp. (CELG) Message Board

usagary1 295 posts  |  Last Activity: 7 hours ago Member since: Jul 29, 2003
  • For tax collections.....picking on small cap biotechs saying the are inflated and the media companies.that could bring in a trillion in federal taxes if sold down.''this surely means the economy will be picking up nicely by end of summer.

  • Also the cost is much ckeaper than a lifetime of other treatments for Hep-c

  • rigged......just another scam to sell then buy back

  • usagary1 by usagary1 Jul 10, 2014 7:56 AM Flag

    Markets will change on small caps........it is just the movement of tax collections and driving down to restart

  • I am down bad on other biotechs big time.

  • losing 30 mil.........CEO will more than likely suffer.....

  • Reply to

    Shame Shame on shorts

    by usagary1 Jul 8, 2014 8:51 AM
    usagary1 usagary1 Jul 8, 2014 8:59 AM Flag

    Dear Duchenne community and Alliance supporters: It has come to my attention through multiple outlets that there is skepticism as to whether Eteplirsen actually works given my recent comments to local and national media groups. My comments about my boys not being able to hold a cup during a running race to hand out water was taken bit out of context. Jack and Nolan have no problem drinking, eating, nor brushing their own teeth. They are still able to write proficiently, use video game controllers, and type on their computers. It is absolutely MADDENING that there are those out there looking to deep-six this drug so quickly based on and out-of-context remark. True...they struggle holding their arms outstretched with 12 oz cups of water waiting for hundreds of runners to pass by and rip them from their hands. Hell, I have a problem doing it sometimes. SHAME on those casting dispersions about Eteplirsen; looking to use this as an opportunity to tear down this drug...especially after what Jack, Nolan, and 10 other boys, their families, and Sarepta have been through these past 4 years to get this drug off the launch pad. Talk about being kicked while you're down? I'm disappointed that I even have to address this situation to a community I have immersed my life in and and fought so hard for. Shame...

    Sarepta cannot comment publicly about individual patients in the eteplirsen study, said company spokesman Baker.

  • Last week, Allison Willis, the mother of Jack and Nolan, was quoted in a local news story lamenting her sons' loss of upper body strength. Here's the relevant passage from the article:
    Handing out cups of water during the Cazenovia 4th of July Foot Races is a family tradition for Alison Dwyer Willis, but she recently realized her 12-year-old twins wouldn't be able to take part this year. "The upper body strength of my twins is just not enough to even hold the cups. So I was faced with the decision of what do we do at the Fourth of July now? We've always been out there," said Willis.
    Investors saw the article and freaked out on Sarepta.
    In response, Allison Willis wrote an email to the DMD community, addressing her comments in the article. Here's her email, in full:
    Dear Duchenne community and Alliance supporters: It has come to my attention through multiple outlets that there is skepticism as to whether Eteplirsen actually works given my recent comments to local and national media groups. My comments about my boys not being able to hold a cup during a running race to hand out water was taken bit out of context. Jack and Nolan have no problem drinking, eating, nor brushing their own teeth. They are still able to write proficiently, use video game controllers, and type on their computers. It is absolutely MADDENING that there are those out there looking to deep-six this drug so quickly based on and out-of-context remark. True...they struggle holding their arms outstretched with 12 oz cups of water waiting for hundreds of runners to pass by and rip them from their hands. Hell, I have a problem doing it sometimes. SHAME on those casting dispersions about Eteplirsen; looking to use this as an opportunity to tear down this drug...especially after what Jack, Nolan, and 10 other boys, their families, and Sarepta have been through these past 4 years to get this drug off the launch pad. Talk about being kicked while you're down? I'm disappointed that I even have to ad

  • Reply to

    "Material"

    by greyzone513 Jul 7, 2014 3:43 PM
    usagary1 usagary1 Jul 8, 2014 7:33 AM Flag

    Section 5 Corporate Governance and Management
    Item 5.01 Changes in Control of Registrant
    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.04 Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
    Item 5.05 Amendment to Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
    Item 5.06 Change in Shell Company Status
    Item 5.07 Submission of Matters to a Vote of Security Holders
    Item 5.08 Shareholder Director Nominations

    Section 6 Asset-Backed Securities
    Item 6.01 ABS Informational and Computational Material
    Item 6.02 Change of Servicer or Trustee
    Item 6.03 Change in Credit Enhancement or Other External Support
    Item 6.04 Failure to Make a Required Distribution
    Item 6.05 Securities Act Updating Disclosure

    Section 7 Regulation FD
    Item 7.01 Regulation FD Disclosure

    Section 8 Other Events
    Item 8.01 Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)

  • Reply to

    "Material"

    by greyzone513 Jul 7, 2014 3:43 PM
    usagary1 usagary1 Jul 8, 2014 7:26 AM Flag

    plain and simple, the stock price decline was just the market and short sellers .

  • so this is all a hoax of rigging...................... buying may start sinse that have suckers shares .

  • Reply to

    Biotech Market Decline

    by iloveallahgod Jul 7, 2014 1:47 PM
    usagary1 usagary1 Jul 7, 2014 2:07 PM Flag

    I am down on all of my biotechs 5 percent or more for no reasons......

    like i said empty out and take money on shorting,send weak hands running just to start the second half of the year up for major gains by getting in super cheap/

  • usagary1 usagary1 Jul 7, 2014 11:52 AM Flag

    20 percent small cap decline shorts 80 percent...
    it is not that uncommon to drive down the only real investment stocks to chase out losses so they can reinvent the second 1/2 of the year gains on the only real growth stocks...

  • since his 38.00 a share buy ,I feel fine,,

  • Very clear and the lesson is near...........................

  • July 2, 2014 / Comments Off
    By Christine McSherry
    Last month, members of the Duchenne Alliance including the Jett Foundation’s Christine McSherry and Jenn McNary; Tracy Seckler from Charley’s Fund and fellow patient advocate, Mindy Leffler had a private meeting with Senator Elizabeth Warren in her Cambridge, MA offices to discuss ways to keep the dialogue going about Duchenne. The Senator’s longtime health care advisor in Washington and avid supporter of our cause, Remy Brim PhD, also joined us that day.
    Over the past several years, members of the Duchenne Alliance – parent advocates and supporters – have had the unique experience of dealing first-hand with the FDA as it works to implement the mandates set forth in the FDA Safety and Innovation Act (FDASIA), and as they relate to new treatments to stop the advancement of Duchenne Muscular Dystrophy. We believe our perspective may be useful to committee members as they consider how best to ensure the soonest possible access to safe and effective therapies for the treatment of the disease.
    Our first objective for the meeting was to thank Senator Warren and Remy for their efforts to date in encouraging the FDA to follow FDASIA regarding Duchenne and the drug Eteplirsen from Sarepta Therapeutics. Shortly following Sarepta’s public announcement that they were given a clear pathway for drug approval, Prosensa, another pharmaceutical company in the Duchenne RNA therapeutic space, announced that they, too, received unprecedented news from the regulators at the FDA about their drug Drisapersen – demonstrating an extraordinary level of flexibility by the agency. During our visit, we also thanked the Senator for signing off on another Duchenne community initiative, the re-authorization of the MD – CARE Act, which has been extremely successful in creating additional programs in the Duchenne community since its inception in 2001 by Parent Project Muscular Dystrophy. We respectfully added, however, that there is still much work t

  • and see if you see anything ......

  • Reply to

    Don't Freak out!

    by kgrichard5 Jul 7, 2014 11:02 AM
    usagary1 usagary1 Jul 7, 2014 11:12 AM Flag

    also that would be a materal event and would been seen in the 120 week data

  • Reply to

    Don't Freak out!

    by kgrichard5 Jul 7, 2014 11:02 AM
    usagary1 usagary1 Jul 7, 2014 11:11 AM Flag

    if true it would be the oldest ones....you must start as early as possible...

CELG
87.765+0.605(+0.69%)3:19 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.